Several of its authors have declared potential conflicts of interest, as outside of this study they are affiliated with companies that commercialize semaglutide drugs, such as Novo Nordisk, Sanofi, Eli Lilly, and AstraZeneca
GLP-1 RAs may also reduce the number of dermal -T cells and IL-17 mRNA expression in psoriasis plaques in patients with diabetes [13, 22]
Clinical Benefits Specifically stimulates growth hormone without affecting cortisol, prolactin, or ACTHavoiding unwanted hormonal side effects common with older peptides
Research measuring inflammatory markers shows the combination lowers pro-inflammatory cytokines (IL-6, TNF-alpha) by 6080%, versus 3040% for either peptide alone translating to less pain, less swelling, and a faster return to function without sacrificing healing quality